OraSure Technologies, Inc. (OSUR) Earnings Call Transcripts

OraSure Technologies, Inc.'s Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, OraSure Technologies, Inc. reported total revenue of $27.9 million, exceeding the midpoint of their guidance range and reflecting a 4% sequential growth. The company experienced gross margin expansion, with GAAP gross margin rising to 42.3% from 41.1% in Q1 2025. Management maintained guidance for Q2 revenue between $27 million and $30 million, signaling confidence in upcoming product launches and operational efficiencies.

Reported metrics

Guidance from management

Management expects Q2 revenue between $27 million and $30 million, with gross margins anticipated to be similar to Q1 levels. Operating expenses are projected to decline further in Q3 as non-recurring expenses wind down.

What management said

Thanks, Ken. As we move through 2026, OraSure is positioned to accelerate our growth as we approach a series of regulatory and commercial milestones, and we continue to transform our business as we deliver on our strategy to decentralize diagnostics. We are excited about all of our opportunities, near-term and long-term, to expand our portfolio with our innovative product pipeline and our ability to leverage our manu...

Sure. Thanks, Brendan. So as far as near-shoring, we're really excited about the opportunity. And just for background, this is something that we've been working with these countries for several years to put in place. We did -- we said it was significant. We haven't given an exact number as far as dollars, but you can imagine in the millions is significant for us. And not all will be -- all relationships will be in t...

What analysts pressed on

Analysts expressed concerns regarding the potential impact of muted demand in academic and government markets on future growth. Additionally, there were inquiries about the ramp-up period for new product launches and its effect on margins.

Main topics on the call

• Revenue Growth — OraSure's total revenue for Q1 2026 was $27.9 million, which reflects a 4% sequential increase. Management noted that diagnostics revenue grew 12% sequentially, indicating strong demand in this segment.
• Gross Margin Expansion — The company achieved a GAAP gross margin of 42.3%, up from 41.1% in the prior year. This improvement was attributed to operational efficiencies from in-sourcing production, which management believes will continue to enha...
• Product Launches — Management highlighted two significant product launches anticipated for mid-year: a rapid molecular self-test for chlamydia and gonorrhoeae, and the Colli-Pee at-home urine collection device. These launches are expected ...
• Near-Shoring Initiatives — OraSure is advancing its near-shoring initiatives, which are expected to generate significant revenue in the millions. Management is optimistic about establishing closer relationships with distribution partners in Africa...

Read the full OraSure Technologies, Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 36 OraSure Technologies, Inc. earnings call transcripts on record, spanning January 16, 2020 to August 5, 2026. Based on this history, OraSure Technologies, Inc. reports quarterly. The most recent call on file is dated August 5, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

OSUR

Exchange

NasdaqGS

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

36

First call

January 16, 2020

Most recent

August 5, 2026

Reporting cadence

quarterly